News

UMIP Wins Tech Transfer Award

The University of Manchester's intellectual property commercialisation company, UMIP, was voted Technology Transfer Office of the Year at the Genesis biotechnology conference in London last night.

The judges at the Gala dinner, held at the Queen Elizabeth II Conference Centre, awarded UMIP the top prize, despite strong competition from the other two shortlisted companies; Cancer Research Technology Ltd and UCL Business plc.

Commenting on the award Clive Rowland, CEO of UMIP, said: "It is an honour to receive this award and it is testament to all the dedication and hard work of UMIP staff. It has been a strong year for us with many new technologies having been either licensed or spun-out creating companies to bring ground breaking new technologies to the marketplace."

In financial terms, over the last 5 years, UMIP's activities have generated over £35M for the University through the sale of shares in spin-outs, licensing income and through IP grants and contracts activity.

This year UMIP has seen award-winning Myconostica pick up the 'Innovation in Diagnostics Project of the Year' prize at the Northwest Biomedical Awards. Also, spin out company Renephra received the 'Emerging Technology Project of the Year' at the same ceremony, as well as the 'Northwest NHS Innovations Award' at a separate event.

Also, clean-tech spin-out company Arvia® Technology won the Institution of Engineering and Technology's (IET) North West Innovation Award in July and were named a Global Cleantech 100 company by Guardian News and Media and Cleantech Group™.